GlassScriptPhysician profile
Maria L Rosen
NPI 1316923618
$1,239.85
in general payments reported to CMS, 2019-2025
15 companies · $50.87 in 2025
The $50.87 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.46 · 2022: $301 · 2023: $418 · 2024: $385 · 2025: $50.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $320.85 | 2021-2024 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $177.41 | 2022-2024 | Andexxa, Breztri |
| Merck Sharp & Dohme LLC | $167.73 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbott Laboratories | $164.67 | 2023 | Proclaim, Eterna |
| Exact Sciences Corporation | $104.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $102.09 | 2023-2024 | |
| Amgen INC. | $52.46 | 2024-2025 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $36.80 | 2022 | |
| Cranial Technologies, INC | $19.92 | 2025 | Doc Band |
| Boston Scientific Corporation | $17.88 | 2023 | |
| Sanofi Pasteur INC. | $16.62 | 2021 | |
| Smith+Nephew, INC. | $16.32 | 2024 | Acticoat 4" X 4", Renasys |
| Medtronic, INC. | $15.96 | 2024 | Intellis Adaptivestim |
| Organon LLC | $13.81 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $13.02 | 2023 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.